Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
申请人:Merck Frosst Canada, Inc.
公开号:US05472964A1
公开(公告)日:1995-12-05
Compounds having the formula I: ##STR1## are antagonists of the actions of leukotrienes. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A
申请人:Geneste Hervé
公开号:US20130005705A1
公开(公告)日:2013-01-03
The present invention relates to novel carboxamide compounds, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating or controlling medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.
SUBSTITUTED BENZOTHIOPHENYL DERIVATIVES AS GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES
申请人:Janssen Pharmaceutica NV
公开号:US20170291908A1
公开(公告)日:2017-10-12
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (I) as follows:
wherein U
1
, U
2
, U
3
, R
1
, R
2
, Z, and W are defined herein.
Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of
申请人:Merck Frosst Canada, Inc.
公开号:US05374635A1
公开(公告)日:1994-12-20
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomemlar nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.
Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
申请人:——
公开号:US20020052346A1
公开(公告)日:2002-05-02
The invention encompasses the novel class of compounds represented by formula I which are inhibitors of the PTP-1B enzyme.
1
The invention also encompasses pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes, obesity, and diabetes-related conditions.